Avadel Pharmaceuticals-adr(AVDL)
$17.97▲0.9%
Market is closed - opens 7 PM, 30 Apr 2024
Insights
- Avadel Pharmaceuticals-adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Avadel Pharmaceuticals-adr stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Avadel Pharmaceuticals-adr stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Avadel Pharmaceuticals-adr stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 59.8 | Neutral |
Stochastic | 71.11, 69.81 | Neutral |
Ultimate Oscillator | 55.09 | Neutral |
Stochastic Relative Strength Index | 61.17, 64.37 | Neutral |
Moving Average Convergence Divergence | 0.49, 0.47 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 17.65 | Buy |
20 | 17.06 | Buy |
50 | 15.89 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 17.53 | Buy |
20 | 17.16 | Buy |
50 | 16.26 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 17.54 | Neutral |
20 | 17.11 | Buy |
50 | 15.46 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 17.88 | Buy |
20 | 17.82 | Buy |
50 | 17.52 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 17.91 | Buy |
20 | 17.87 | Buy |
50 | 17.8 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 19.05 |
Resistance L2 | 18.45 |
Resistance L1 | 18.14 |
Pivot Point | 17.54 |
Support L1 | 17.23 |
Support L2 | 16.63 |
Support L3 | 16.32 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.